nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.28	1	CrCrCtD
Fluticasone furoate—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.264	0.424	CbGbCtD
Fluticasone furoate—NR3C1—Progesterone—uterine cancer	0.175	0.281	CbGbCtD
Fluticasone furoate—ABCB1—Progesterone—uterine cancer	0.0407	0.0654	CbGbCtD
Fluticasone furoate—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0368	0.0592	CbGbCtD
Fluticasone furoate—ABCB1—Dactinomycin—uterine cancer	0.0323	0.0519	CbGbCtD
Fluticasone furoate—CYP3A4—Progesterone—uterine cancer	0.0244	0.0392	CbGbCtD
Fluticasone furoate—ABCB1—Etoposide—uterine cancer	0.0182	0.0293	CbGbCtD
Fluticasone furoate—ABCB1—Doxorubicin—uterine cancer	0.0124	0.02	CbGbCtD
Fluticasone furoate—CYP3A4—Etoposide—uterine cancer	0.0109	0.0175	CbGbCtD
Fluticasone furoate—CYP3A4—Doxorubicin—uterine cancer	0.00744	0.012	CbGbCtD
Fluticasone furoate—Growth retardation—Dactinomycin—uterine cancer	0.00461	0.0493	CcSEcCtD
Fluticasone furoate—Blood glucose increased—Progesterone—uterine cancer	0.00289	0.031	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Progesterone—uterine cancer	0.00271	0.029	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Medroxyprogesterone Acetate—uterine cancer	0.00266	0.0285	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Medroxyprogesterone Acetate—uterine cancer	0.00255	0.0273	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Medroxyprogesterone Acetate—uterine cancer	0.00246	0.0263	CcSEcCtD
Fluticasone furoate—Toothache—Progesterone—uterine cancer	0.00244	0.026	CcSEcCtD
Fluticasone furoate—Menorrhagia—Progesterone—uterine cancer	0.002	0.0214	CcSEcCtD
Fluticasone furoate—Menorrhagia—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.0194	CcSEcCtD
Fluticasone furoate—Dysphonia—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.0175	CcSEcCtD
Fluticasone furoate—Herpes simplex—Progesterone—uterine cancer	0.00161	0.0172	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Progesterone—uterine cancer	0.00148	0.0158	CcSEcCtD
Fluticasone furoate—Ulcer—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.0152	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.0144	CcSEcCtD
Fluticasone furoate—Visual disturbance—Progesterone—uterine cancer	0.00113	0.0121	CcSEcCtD
Fluticasone furoate—Ulcer—Dactinomycin—uterine cancer	0.00111	0.0118	CcSEcCtD
Fluticasone furoate—Migraine—Progesterone—uterine cancer	0.00106	0.0113	CcSEcCtD
Fluticasone furoate—Visual disturbance—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.011	CcSEcCtD
Fluticasone furoate—Infection—Carboplatin—uterine cancer	0.001	0.0107	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Progesterone—uterine cancer	0.000962	0.0103	CcSEcCtD
Fluticasone furoate—Migraine—Medroxyprogesterone Acetate—uterine cancer	0.000959	0.0103	CcSEcCtD
Fluticasone furoate—Bronchitis—Progesterone—uterine cancer	0.000894	0.00956	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.000871	0.00932	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Epirubicin—uterine cancer	0.000842	0.009	CcSEcCtD
Fluticasone furoate—Bronchitis—Medroxyprogesterone Acetate—uterine cancer	0.00081	0.00866	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Epirubicin—uterine cancer	0.000808	0.00864	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Progesterone—uterine cancer	0.000805	0.00862	CcSEcCtD
Fluticasone furoate—Ulcer—Etoposide—uterine cancer	0.000801	0.00857	CcSEcCtD
Fluticasone furoate—Body temperature increased—Carboplatin—uterine cancer	0.000795	0.00851	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Doxorubicin—uterine cancer	0.000779	0.00833	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Epirubicin—uterine cancer	0.000777	0.00831	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Doxorubicin—uterine cancer	0.000748	0.008	CcSEcCtD
Fluticasone furoate—Pharyngitis—Progesterone—uterine cancer	0.000738	0.0079	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Progesterone—uterine cancer	0.000731	0.00782	CcSEcCtD
Fluticasone furoate—Candida infection—Etoposide—uterine cancer	0.000723	0.00774	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Doxorubicin—uterine cancer	0.000719	0.00769	CcSEcCtD
Fluticasone furoate—Visual impairment—Progesterone—uterine cancer	0.000717	0.00767	CcSEcCtD
Fluticasone furoate—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.000708	0.00758	CcSEcCtD
Fluticasone furoate—Eye disorder—Progesterone—uterine cancer	0.000695	0.00744	CcSEcCtD
Fluticasone furoate—Immune system disorder—Progesterone—uterine cancer	0.000672	0.00719	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Progesterone—uterine cancer	0.00067	0.00717	CcSEcCtD
Fluticasone furoate—Pharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.000669	0.00716	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.000662	0.00709	CcSEcCtD
Fluticasone furoate—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00065	0.00695	CcSEcCtD
Fluticasone furoate—Fluticasone Propionate—PGR—uterine cancer	0.000637	0.241	CrCbGaD
Fluticasone furoate—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00063	0.00674	CcSEcCtD
Fluticasone furoate—Back pain—Progesterone—uterine cancer	0.000626	0.0067	CcSEcCtD
Fluticasone furoate—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000609	0.00651	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000608	0.0065	CcSEcCtD
Fluticasone furoate—Tremor—Progesterone—uterine cancer	0.000607	0.00649	CcSEcCtD
Fluticasone furoate—Angioedema—Progesterone—uterine cancer	0.000592	0.00633	CcSEcCtD
Fluticasone furoate—Betamethasone—PGR—uterine cancer	0.000584	0.221	CrCbGaD
Fluticasone furoate—Palpitations—Progesterone—uterine cancer	0.000572	0.00612	CcSEcCtD
Fluticasone furoate—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.000568	0.00607	CcSEcCtD
Fluticasone furoate—Cough—Progesterone—uterine cancer	0.000565	0.00604	CcSEcCtD
Fluticasone furoate—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00055	0.00588	CcSEcCtD
Fluticasone furoate—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000539	0.00577	CcSEcCtD
Fluticasone furoate—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000536	0.00574	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Progesterone—uterine cancer	0.000529	0.00565	CcSEcCtD
Fluticasone furoate—Infection—Progesterone—uterine cancer	0.000525	0.00562	CcSEcCtD
Fluticasone furoate—Pharyngitis—Dactinomycin—uterine cancer	0.000522	0.00558	CcSEcCtD
Fluticasone furoate—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000519	0.00555	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Progesterone—uterine cancer	0.000518	0.00554	CcSEcCtD
Fluticasone furoate—Dysphonia—Epirubicin—uterine cancer	0.000516	0.00552	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000479	0.00512	CcSEcCtD
Fluticasone furoate—Dysphonia—Doxorubicin—uterine cancer	0.000478	0.00511	CcSEcCtD
Fluticasone furoate—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000476	0.00509	CcSEcCtD
Fluticasone furoate—Dyspnoea—Progesterone—uterine cancer	0.000471	0.00504	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00047	0.00502	CcSEcCtD
Fluticasone furoate—Herpes simplex—Epirubicin—uterine cancer	0.000461	0.00493	CcSEcCtD
Fluticasone furoate—Dexamethasone—CYP11A1—uterine cancer	0.000451	0.17	CrCbGaD
Fluticasone furoate—Ulcer—Epirubicin—uterine cancer	0.000449	0.0048	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Epirubicin—uterine cancer	0.000438	0.00468	CcSEcCtD
Fluticasone furoate—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000427	0.00457	CcSEcCtD
Fluticasone furoate—Herpes simplex—Doxorubicin—uterine cancer	0.000426	0.00456	CcSEcCtD
Fluticasone furoate—Urticaria—Progesterone—uterine cancer	0.00042	0.00449	CcSEcCtD
Fluticasone furoate—Body temperature increased—Progesterone—uterine cancer	0.000418	0.00447	CcSEcCtD
Fluticasone furoate—Ulcer—Doxorubicin—uterine cancer	0.000416	0.00445	CcSEcCtD
Fluticasone furoate—Candida infection—Epirubicin—uterine cancer	0.000406	0.00434	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Doxorubicin—uterine cancer	0.000405	0.00433	CcSEcCtD
Fluticasone furoate—Betamethasone—CYP19A1—uterine cancer	0.000401	0.151	CrCbGaD
Fluticasone furoate—Hypersensitivity—Progesterone—uterine cancer	0.000389	0.00417	CcSEcCtD
Fluticasone furoate—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00038	0.00407	CcSEcCtD
Fluticasone furoate—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000379	0.00405	CcSEcCtD
Fluticasone furoate—Candida infection—Doxorubicin—uterine cancer	0.000375	0.00401	CcSEcCtD
Fluticasone furoate—Infection—Dactinomycin—uterine cancer	0.000371	0.00397	CcSEcCtD
Fluticasone furoate—Diarrhoea—Progesterone—uterine cancer	0.000362	0.00387	CcSEcCtD
Fluticasone furoate—Eye disorder—Etoposide—uterine cancer	0.000356	0.0038	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000353	0.00377	CcSEcCtD
Fluticasone furoate—Dizziness—Progesterone—uterine cancer	0.000349	0.00374	CcSEcCtD
Fluticasone furoate—Immune system disorder—Etoposide—uterine cancer	0.000344	0.00368	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Etoposide—uterine cancer	0.000343	0.00367	CcSEcCtD
Fluticasone furoate—Dexamethasone—PGR—uterine cancer	0.00034	0.128	CrCbGaD
Fluticasone furoate—Rash—Progesterone—uterine cancer	0.000333	0.00356	CcSEcCtD
Fluticasone furoate—Dermatitis—Progesterone—uterine cancer	0.000333	0.00356	CcSEcCtD
Fluticasone furoate—Headache—Progesterone—uterine cancer	0.000331	0.00354	CcSEcCtD
Fluticasone furoate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000328	0.00351	CcSEcCtD
Fluticasone furoate—Back pain—Etoposide—uterine cancer	0.00032	0.00343	CcSEcCtD
Fluticasone furoate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000317	0.00339	CcSEcCtD
Fluticasone furoate—Nausea—Progesterone—uterine cancer	0.000314	0.00336	CcSEcCtD
Fluticasone furoate—Migraine—Epirubicin—uterine cancer	0.000304	0.00325	CcSEcCtD
Fluticasone furoate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000302	0.00323	CcSEcCtD
Fluticasone furoate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000302	0.00323	CcSEcCtD
Fluticasone furoate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.0003	0.00321	CcSEcCtD
Fluticasone furoate—Body temperature increased—Dactinomycin—uterine cancer	0.000295	0.00316	CcSEcCtD
Fluticasone furoate—Cough—Etoposide—uterine cancer	0.000289	0.00309	CcSEcCtD
Fluticasone furoate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000284	0.00304	CcSEcCtD
Fluticasone furoate—Migraine—Doxorubicin—uterine cancer	0.000281	0.003	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Epirubicin—uterine cancer	0.000276	0.00295	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Dactinomycin—uterine cancer	0.000275	0.00294	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Etoposide—uterine cancer	0.00027	0.00289	CcSEcCtD
Fluticasone furoate—Infection—Etoposide—uterine cancer	0.000269	0.00287	CcSEcCtD
Fluticasone furoate—Bronchitis—Epirubicin—uterine cancer	0.000256	0.00274	CcSEcCtD
Fluticasone furoate—Diarrhoea—Dactinomycin—uterine cancer	0.000256	0.00273	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Doxorubicin—uterine cancer	0.000255	0.00273	CcSEcCtD
Fluticasone furoate—Dyspnoea—Etoposide—uterine cancer	0.000241	0.00258	CcSEcCtD
Fluticasone furoate—Bronchitis—Doxorubicin—uterine cancer	0.000237	0.00254	CcSEcCtD
Fluticasone furoate—Rash—Dactinomycin—uterine cancer	0.000236	0.00252	CcSEcCtD
Fluticasone furoate—Dexamethasone—CYP19A1—uterine cancer	0.000233	0.0881	CrCbGaD
Fluticasone furoate—Conjunctivitis—Epirubicin—uterine cancer	0.000231	0.00247	CcSEcCtD
Fluticasone furoate—Epistaxis—Epirubicin—uterine cancer	0.000224	0.0024	CcSEcCtD
Fluticasone furoate—Nausea—Dactinomycin—uterine cancer	0.000222	0.00237	CcSEcCtD
Fluticasone furoate—Urticaria—Etoposide—uterine cancer	0.000215	0.0023	CcSEcCtD
Fluticasone furoate—Body temperature increased—Etoposide—uterine cancer	0.000214	0.00229	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Doxorubicin—uterine cancer	0.000214	0.00229	CcSEcCtD
Fluticasone furoate—Pharyngitis—Epirubicin—uterine cancer	0.000212	0.00226	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Epirubicin—uterine cancer	0.00021	0.00224	CcSEcCtD
Fluticasone furoate—Epistaxis—Doxorubicin—uterine cancer	0.000207	0.00222	CcSEcCtD
Fluticasone furoate—Visual impairment—Epirubicin—uterine cancer	0.000206	0.0022	CcSEcCtD
Fluticasone furoate—Eye disorder—Epirubicin—uterine cancer	0.000199	0.00213	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Etoposide—uterine cancer	0.000199	0.00213	CcSEcCtD
Fluticasone furoate—Pharyngitis—Doxorubicin—uterine cancer	0.000196	0.0021	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Doxorubicin—uterine cancer	0.000194	0.00207	CcSEcCtD
Fluticasone furoate—Immune system disorder—Epirubicin—uterine cancer	0.000193	0.00206	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Epirubicin—uterine cancer	0.000192	0.00206	CcSEcCtD
Fluticasone furoate—Visual impairment—Doxorubicin—uterine cancer	0.00019	0.00203	CcSEcCtD
Fluticasone furoate—Diarrhoea—Etoposide—uterine cancer	0.000185	0.00198	CcSEcCtD
Fluticasone furoate—Eye disorder—Doxorubicin—uterine cancer	0.000184	0.00197	CcSEcCtD
Fluticasone furoate—Back pain—Epirubicin—uterine cancer	0.00018	0.00192	CcSEcCtD
Fluticasone furoate—Dizziness—Etoposide—uterine cancer	0.000179	0.00191	CcSEcCtD
Fluticasone furoate—Immune system disorder—Doxorubicin—uterine cancer	0.000178	0.00191	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Doxorubicin—uterine cancer	0.000178	0.0019	CcSEcCtD
Fluticasone furoate—Agitation—Epirubicin—uterine cancer	0.000171	0.00183	CcSEcCtD
Fluticasone furoate—Rash—Etoposide—uterine cancer	0.00017	0.00182	CcSEcCtD
Fluticasone furoate—Dermatitis—Etoposide—uterine cancer	0.00017	0.00182	CcSEcCtD
Fluticasone furoate—Headache—Etoposide—uterine cancer	0.000169	0.00181	CcSEcCtD
Fluticasone furoate—Back pain—Doxorubicin—uterine cancer	0.000166	0.00178	CcSEcCtD
Fluticasone furoate—Palpitations—Epirubicin—uterine cancer	0.000164	0.00176	CcSEcCtD
Fluticasone furoate—Cough—Epirubicin—uterine cancer	0.000162	0.00173	CcSEcCtD
Fluticasone furoate—Nausea—Etoposide—uterine cancer	0.000161	0.00172	CcSEcCtD
Fluticasone furoate—Agitation—Doxorubicin—uterine cancer	0.000158	0.00169	CcSEcCtD
Fluticasone furoate—Palpitations—Doxorubicin—uterine cancer	0.000152	0.00162	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Epirubicin—uterine cancer	0.000152	0.00162	CcSEcCtD
Fluticasone furoate—Infection—Epirubicin—uterine cancer	0.000151	0.00161	CcSEcCtD
Fluticasone furoate—Cough—Doxorubicin—uterine cancer	0.00015	0.0016	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Epirubicin—uterine cancer	0.000149	0.00159	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Doxorubicin—uterine cancer	0.00014	0.0015	CcSEcCtD
Fluticasone furoate—Infection—Doxorubicin—uterine cancer	0.000139	0.00149	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Doxorubicin—uterine cancer	0.000138	0.00147	CcSEcCtD
Fluticasone furoate—Dyspnoea—Epirubicin—uterine cancer	0.000135	0.00145	CcSEcCtD
Fluticasone furoate—Dyspnoea—Doxorubicin—uterine cancer	0.000125	0.00134	CcSEcCtD
Fluticasone furoate—NR3C1—myometrium—uterine cancer	0.000123	0.0709	CbGeAlD
Fluticasone furoate—Urticaria—Epirubicin—uterine cancer	0.00012	0.00129	CcSEcCtD
Fluticasone furoate—Body temperature increased—Epirubicin—uterine cancer	0.00012	0.00128	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Epirubicin—uterine cancer	0.000112	0.00119	CcSEcCtD
Fluticasone furoate—Urticaria—Doxorubicin—uterine cancer	0.000111	0.00119	CcSEcCtD
Fluticasone furoate—Body temperature increased—Doxorubicin—uterine cancer	0.000111	0.00119	CcSEcCtD
Fluticasone furoate—Diarrhoea—Epirubicin—uterine cancer	0.000104	0.00111	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Doxorubicin—uterine cancer	0.000103	0.00111	CcSEcCtD
Fluticasone furoate—Dizziness—Epirubicin—uterine cancer	0.0001	0.00107	CcSEcCtD
Fluticasone furoate—NR3C1—epithelium—uterine cancer	9.65e-05	0.0557	CbGeAlD
Fluticasone furoate—Diarrhoea—Doxorubicin—uterine cancer	9.59e-05	0.00103	CcSEcCtD
Fluticasone furoate—NR3C1—uterine cervix—uterine cancer	9.57e-05	0.0552	CbGeAlD
Fluticasone furoate—Rash—Epirubicin—uterine cancer	9.56e-05	0.00102	CcSEcCtD
Fluticasone furoate—Dermatitis—Epirubicin—uterine cancer	9.55e-05	0.00102	CcSEcCtD
Fluticasone furoate—Headache—Epirubicin—uterine cancer	9.49e-05	0.00102	CcSEcCtD
Fluticasone furoate—NR3C1—smooth muscle tissue—uterine cancer	9.3e-05	0.0536	CbGeAlD
Fluticasone furoate—Dizziness—Doxorubicin—uterine cancer	9.27e-05	0.000992	CcSEcCtD
Fluticasone furoate—NR3C1—decidua—uterine cancer	9.11e-05	0.0526	CbGeAlD
Fluticasone furoate—Nausea—Epirubicin—uterine cancer	9e-05	0.000963	CcSEcCtD
Fluticasone furoate—NR3C1—renal system—uterine cancer	8.95e-05	0.0516	CbGeAlD
Fluticasone furoate—Rash—Doxorubicin—uterine cancer	8.84e-05	0.000946	CcSEcCtD
Fluticasone furoate—Dermatitis—Doxorubicin—uterine cancer	8.83e-05	0.000945	CcSEcCtD
Fluticasone furoate—Headache—Doxorubicin—uterine cancer	8.78e-05	0.00094	CcSEcCtD
Fluticasone furoate—NR3C1—endometrium—uterine cancer	8.65e-05	0.0499	CbGeAlD
Fluticasone furoate—NR3C1—mammalian vulva—uterine cancer	8.37e-05	0.0483	CbGeAlD
Fluticasone furoate—Nausea—Doxorubicin—uterine cancer	8.33e-05	0.000891	CcSEcCtD
Fluticasone furoate—NR3C1—uterus—uterine cancer	7.97e-05	0.046	CbGeAlD
Fluticasone furoate—NR3C1—female reproductive system—uterine cancer	7.17e-05	0.0413	CbGeAlD
Fluticasone furoate—CYP3A4—renal system—uterine cancer	6.77e-05	0.039	CbGeAlD
Fluticasone furoate—ABCB1—myometrium—uterine cancer	6.58e-05	0.038	CbGeAlD
Fluticasone furoate—NR3C1—female gonad—uterine cancer	6.52e-05	0.0376	CbGeAlD
Fluticasone furoate—NR3C1—vagina—uterine cancer	6.48e-05	0.0374	CbGeAlD
Fluticasone furoate—CYP3A4—female reproductive system—uterine cancer	5.42e-05	0.0313	CbGeAlD
Fluticasone furoate—ABCB1—epithelium—uterine cancer	5.16e-05	0.0298	CbGeAlD
Fluticasone furoate—ABCB1—uterine cervix—uterine cancer	5.12e-05	0.0295	CbGeAlD
Fluticasone furoate—ABCB1—decidua—uterine cancer	4.88e-05	0.0281	CbGeAlD
Fluticasone furoate—ABCB1—renal system—uterine cancer	4.79e-05	0.0276	CbGeAlD
Fluticasone furoate—ABCB1—endometrium—uterine cancer	4.63e-05	0.0267	CbGeAlD
Fluticasone furoate—ABCB1—mammalian vulva—uterine cancer	4.48e-05	0.0258	CbGeAlD
Fluticasone furoate—ABCB1—uterus—uterine cancer	4.27e-05	0.0246	CbGeAlD
Fluticasone furoate—NR3C1—lymph node—uterine cancer	4.19e-05	0.0242	CbGeAlD
Fluticasone furoate—ABCB1—female reproductive system—uterine cancer	3.84e-05	0.0221	CbGeAlD
Fluticasone furoate—ABCB1—female gonad—uterine cancer	3.49e-05	0.0201	CbGeAlD
Fluticasone furoate—ABCB1—vagina—uterine cancer	3.47e-05	0.02	CbGeAlD
Fluticasone furoate—ABCB1—lymph node—uterine cancer	2.24e-05	0.0129	CbGeAlD
